Laceration Closure Devices Market Report 2026

Laceration Closure Devices Market Overview

• Laceration Closure Devices market size has reached to $10.31 billion in 2025 • Expected to grow to $14.17 billion in 2030 at a compound annual growth rate (CAGR) of 6.4% • Growth Driver: Impact Of Surgical Procedure Growth On Laceration Closure Device Market • Market Trend: Development of Next-Generation Microsurgical Sutures in the Laceration Closure Devices Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Laceration Closure Devices Market?

Laceration closure devices are medical tools used to close and heal wounds, typically including skin glues and adhesive strips. They provide an efficient method for approximating wound edges to promote faster healing and reduce scarring. These devices are commonly used in emergency settings and surgical procedures. The main types of products in laceration closure devices are staples, hemostats, adhesives, sutures, strips, sealants, wound strips, and mechanical wound closure devices. Staples are surgical devices used to close skin wounds by quickly and securely bringing the wound edges together to promote healing. These products can be used for various wound types, including acute, chronic, burns, ulcers, and surgical wounds, and their end users are hospitals, ambulatory surgery centers, and others.

What Is The Laceration Closure Devices Market Growth Forecast?

The laceration closure devices market size is expected to see strong growth in the next few years. It will grow to $14.17 billion in 2030 at a compound annual growth rate (CAGR) of 6.4%. The growth in the forecast period can be attributed to increasing demand for minimally invasive wound closure methods, growing focus on outpatient and ambulatory care, rising preference for faster healing solutions, expanding access to advanced wound care products, increasing emphasis on patient comfort and cosmetic outcomes. Major trends in the forecast period include growing adoption of non-invasive wound closure solutions, rising preference for skin adhesives and closure strips over sutures, increasing use of laceration closure devices in emergency care, expansion of rapid wound management in outpatient settings, growing focus on reduced scarring and faster healing outcomes.

Global Laceration Closure Devices Market Segmentation

1) By Product: Staples, Adhesives, Sutures, Strips, Wound Strips, Mechanical Wound Closure Devices 2) By Wound Type: Acute, Surgical Wounds 3) By End-User: Hospitals, Ambulatory Surgery Centers, Other End-Users Subsegments: 1) By Staples: Stainless Steel Staples, Titanium Staples 2) By Adhesives: Tissue Adhesives, Surgical Adhesives 3) By Sutures: Absorbable Sutures, Non-Absorbable Sutures 4) By Strips: Steri-Strips, Wound Closure Strips 5) By Wound Strips: Paper Wound Strips, Fabric Wound Strips 6) By Mechanical Wound Closure Devices: Skin Closures, Wound Closure Clips

What Is The Driver Of The Laceration Closure Devices Market?

An increase in the number of surgical procedures is expected to propel the growth of the laceration closure device market going forward. Surgical procedures are medical operations that involve invasive techniques to diagnose, treat, or manage injuries, diseases, or conditions. The number of surgical procedures is rising due to aging populations, advances in medical technology, and increasing demand for elective surgeries. Laceration closure devices are beneficial in surgical procedures for their efficiency in closing wounds, reducing procedure time, minimizing tissue trauma, and promoting faster healing compared to traditional sutures. For instance, in June 2024, according to the International Society of Aesthetic Plastic Surgery (ISAPS), a US-based nonprofit professional organization, total surgical and non-surgical procedures increased by 3.4% in 2023, reaching 34.9 million. This growth was driven by a 5.5% rise in surgical procedures. Plastic surgeons performed over 15.8 million surgical procedures and 19.1 million non-surgical procedures, marking a 40% overall increase in procedures over the past four years. Therefore, an increase in the number of surgical procedures is driving the growth of the laceration closure device industry.

Key Players In The Global Laceration Closure Devices Market

Major companies operating in the laceration closure devices market are Johnson & Johnson, 3M Company, Medtronic plc, Becton Dickinson and Company, B. Braun Melsungen AG, Smith & Nephew plc, Teleflex Incorporated, Integra LifeSciences Corporation, Mölnlycke Health Care AB, Aspen Surgical Products, BSN medical GmbH, Stryker Corporation, Baxter International Inc, Terumo Corporation, Arthrex Inc, Zimmer Biomet Holdings Inc, Meril Life Sciences Pvt Ltd, Healthium Medtech, Medline Industries, Peters Surgical

Global Laceration Closure Devices Market Trends and Insights

Major companies operating in the laceration closure devices market are focusing on developing innovative solutions, such as next-generation microsurgical sutures to enhance precision, reduce healing time, and improve patient outcomes. Next-generation microsurgical sutures refer to advanced, ultra-fine sutures designed for precise, minimally invasive surgical procedures, offering improved biocompatibility, strength, and reduced tissue trauma for better healing and faster recovery. For instance, in October 2024, Corza Medical GmbH, a US-based manufacturing company, launched Onatec Ophthalmic Microsurgical Sutures at American Academy of Ophthalmology Conference. Onatec ophthalmic microsurgical sutures are crafted from highly tempered stainless steel for durability and precision, designed to enhance tissue penetration and reduce trauma during eye surgeries. The advanced manufacturing process ensures optimal geometries for stitching in delicate and small spaces.

What Are Latest Mergers And Acquisitions In The Laceration Closure Devices Market?

In March 2024, Advanced Medical Solutions Group plc, a UK-based developer and manufacturer of innovative tissue-healing technology, acquired Péters Surgical SASU for an undisclosed amount. Through this acquisition, Advanced Medical Solutions aims to create a global leader in tissue repair and skin closure, leveraging complementary product portfolios and expanding direct selling capabilities in key markets, with expectations of high single-digit earnings growth in the first full year. Péters Surgical SASU, a France-based manufacturer and supplier of medical devices and instruments, offers laceration closure devices.

Regional Outlook

North America was the largest region in the laceration closure devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Laceration Closure Devices Market?

The laceration closure devices market consists of sales of products including sutures, staplers, adhesive tapes and glues, and hemostats. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.